Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H A Burris

Showing results (41-50 of 114) with videos related to

Pageof 12
Sort By:
American Journal of Clinical Oncology|February 20, 1999
Phase II trial of docetaxel for cholangiocarcinomaR Pazdur, M E Royce, G I Rodriguez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Improvements in clinical benefit with vinorelbine in the treatment of hormone-refractory prostate cancer: a phase II trialS Fields-Jones, A Koletsky, G Wilding, et al.
Cancer|August 5, 2000
Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma. A Minnie Pearl Cancer Research Network Phase II TrialJ D Hainsworth, H A Burris, S Litchy, et al.
Cancer Investigation|June 19, 2001
Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research NetworkJ D Hainsworth, H A Burris, S W Calvert, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
New anticancer agentsT D Brown, H A Burris, K A Havlin, et al.
Cancer|January 3, 2001
Carcinoma of unknown primary siteF A Greco, H A Burris, J B Erland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2016
Statistical controversies in clinical research: statistical significance-too much of a good thing …M Buyse, S A Hurvitz, F Andre, et al.
British Journal of Cancer|January 16, 2014
Intermittent dosing of axitinib combined with chemotherapy is supported by (18)FLT-PET in gastrointestinal tumoursC K Hoh, H A Burris, J C Bendell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2014
A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinomaB Rini, B Redman, J A Garcia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Phase I study of daily times five topotecan and single injection of cisplatin in patients with previously untreated non-small-cell lung carcinomaE Raymond, H A Burris, E K Rowinsky, et al.
Pageof 12

Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
American Journal of Clinical Oncology|February 20, 1999
Phase II trial of docetaxel for cholangiocarcinomaR Pazdur, M E Royce, G I Rodriguez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2000
Improvements in clinical benefit with vinorelbine in the treatment of hormone-refractory prostate cancer: a phase II trialS Fields-Jones, A Koletsky, G Wilding, et al.
Cancer|August 5, 2000
Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma. A Minnie Pearl Cancer Research Network Phase II TrialJ D Hainsworth, H A Burris, S Litchy, et al.
Cancer Investigation|June 19, 2001
Gemcitabine in the second-line therapy of patients with carcinoma of unknown primary site: a phase II trial of the Minnie Pearl Cancer Research NetworkJ D Hainsworth, H A Burris, S W Calvert, et al.
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991
New anticancer agentsT D Brown, H A Burris, K A Havlin, et al.
Cancer|January 3, 2001
Carcinoma of unknown primary siteF A Greco, H A Burris, J B Erland, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2016
Statistical controversies in clinical research: statistical significance-too much of a good thing …M Buyse, S A Hurvitz, F Andre, et al.
British Journal of Cancer|January 16, 2014
Intermittent dosing of axitinib combined with chemotherapy is supported by (18)FLT-PET in gastrointestinal tumoursC K Hoh, H A Burris, J C Bendell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 11, 2014
A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinomaB Rini, B Redman, J A Garcia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 24, 1997
Phase I study of daily times five topotecan and single injection of cisplatin in patients with previously untreated non-small-cell lung carcinomaE Raymond, H A Burris, E K Rowinsky, et al.
Pageof 12